Neurogene CFO’s 4,800‑Share Sale Signals Optimism Despite Volatile Stock
Neurogene CFO Christine Mikail sells 4,800 shares under a pre‑approved plan, while the company holds FDA breakthrough status—what this means for investors.
3 minutes to read
Neurogene Inc